Karyopharm Therapeutics(DE:25K0)
€0.02-0.01 (-51.22%)
DE:25K0
Karyopharm Therapeutics Revenue
€0.02
At close:-0.01 (-51.22%)
Karyopharm Therapeutics (25K0) Revenue
1 Followers
Karyopharm Therapeutics Revenue
Karyopharm Therapeutics had a revenue of 33.43M in the quarter ending Jun 30, 2026, with -4.66%. This bring the company's revenue in the last twelve months to 146.62M, Decreased 2.98%. In the fiscal year ending Dec 31, 2025, Karyopharm Therapeutics had annual revenue of 146.07M with 0.57% growth.
- Revenue (ttm)
- 146.62M
- Revenue Growth
- -0.18%
- P/S Ratio
- 0.00
- Revenue/Employee
- EUR 640,645
- Employees
- 228
- Market Cap
- EUR 355.66K
Revenue Chart
Karyopharm Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.07M | 830.00K | 0.57% |
| Dec 31, 2024 | 145.24M | -796.00K | -0.55% |
| Dec 31, 2023 | 146.03M | -11.04M | -7.03% |
| Dec 31, 2022 | 157.07M | -52.74M | -25.14% |
| Dec 31, 2021 | 209.82M | 101.73M | 94.12% |
| Dec 31, 2020 | 108.08M | 67.19M | 164.31% |
| Dec 31, 2019 | 40.89M | 10.56M | 34.80% |
| Dec 31, 2018 | 30.34M | 28.73M | 1790.09% |
| Dec 31, 2017 | 1.60M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.